IND enabling

CAMBRIDGE, Mass., Aug. 14, 2026 Enveric Biosciences reported continued progress in the preclinical development of EB-003, its lead next-generation...

WATERTOWN, Massachusetts, April 9, 2026 Kymera Therapeutics has announced that Gilead Sciences has exercised its option to exclusively license...